spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Bioresorbable Stent 

 HSMN NewsFeed - 14 Dec 2020
Efemoral Medical Announces Successful First-In-Human Use of the Efemoral(TM) Vascular Scaffold System
Devices Interventional
 HSMN NewsFeed - 7 Nov 2016
Abbott's Absorb(TM) Bioresorbable Stent Approved as the First Fully Dissolving Heart Stent in Japan
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 30 Oct 2013
REVA Announces Transmission of ReZolve2 Implant and Pilot Trial Update at TCT 2013
Devices Interventional Cardiology
 HSMN NewsFeed - 15 May 2012
Arterial Remodeling Technologies (“ART”) receives regulatory approval to begin First-In-Man “ARTDIVA” clinical trial with its next-generation bioresorbable stent
Devices Interventional Cardiology
 HSMN NewsFeed - 25 Feb 2011
REVA Expands Management Team With Key Executive Hire
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 10 Jan 2011
Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 Dec 2010
Arterial Remodeling Technologies (“ART”) Discloses New Data for Its Breakthrough Bioresorbable Stent
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Sep 2010
Elixir Medical Corporation Initiates Enrollment in the EXCELLA BD Randomized Clinical Trial of the Elixir Novolimus Eluting Coronary Stent System with Bioabsorbable Polymer
Devices Interventional Cardiology
 HSMN NewsFeed - 4 Jan 2010
Arterial Remodeling Technologies ("ART") To Report That Its Bioresorbable Stent Platform Restores the Remodeling Capacity of Arterial Walls
Devices Interventional Cardiology
 HSMN NewsFeed - 24 Mar 2008
Bioresorbable Stent Company, Arterial Remodeling Technologies (''ART''), Appoints Machiel Van Der Leest as Chief Operating Officer
Devices Interventional Cardiology Personnel
Return to NewsFeed  

 Additional items found! 4

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 4 additional stories matching:
Bioresorbable Stent
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.